Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Raemaekers

Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology

English

Retracted: Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray as a Prerequisite for Broad Clinical Applications (A Study From the Lunenburg Lymphoma Biomarker Consortium)

Journal of Clinical Pathology

English

Related publications

Preliminary Results of a Quality Control Study on Involved Node Radiotherapy in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology

English

Treatment of Early Stages Hodgkin Lymphoma During Pregnancy

Mediterranean Journal of Hematology and Infectious Diseases

Infectious Diseases

Hematology

2018

English

Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol

Hematological Oncology

English

Clinico-Biological Characteristics and Treatment Outcomes for Agressive Mantle Cell Lymphoma Patients Included in Clinical Trials. A Lysa Study

Hematological Oncology

English

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma

British Journal of Haematology

Hematology

2017

English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology

Hematology

2018

English

PET/CT and Brown Fat in the Evaluation of Treatment Response in Hodgkin Lymphoma

Radiologia Brasileira

English

Differences in Outcome of Patients With Syncytial Variant Hodgkin Lymphoma Compared With Typical Nodular Sclerosis Hodgkin Lymphoma

Therapeutic Advances in Hematology

Hematology

2016

English

Quantitative Assessment of Interim PET in Hodgkin Lymphoma: An Evaluation of the qPET Method in Adult Patients in the RAPID Trial

PLoS ONE

Multidisciplinary

2020

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. Raemaekers

Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Retracted: Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray as a Prerequisite for Broad Clinical Applications (A Study From the Lunenburg Lymphoma Biomarker Consortium)

Related publications

Preliminary Results of a Quality Control Study on Involved Node Radiotherapy in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Treatment of Early Stages Hodgkin Lymphoma During Pregnancy

Prognostic Value of Immunohistochemical Markers in Stage Iii/Iv Classical Hodgkin Lymphoma Treated Frontline in the Lysa Eortc 20012 Randomized Protocol

Clinico-Biological Characteristics and Treatment Outcomes for Agressive Mantle Cell Lymphoma Patients Included in Clinical Trials. A Lysa Study

Interim FDG-PET Has No Value in Selecting Patients Who Require Treatment Modification in Both Early- And Advanced-Stage Hodgkin Lymphoma

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

PET/CT and Brown Fat in the Evaluation of Treatment Response in Hodgkin Lymphoma

Differences in Outcome of Patients With Syncytial Variant Hodgkin Lymphoma Compared With Typical Nodular Sclerosis Hodgkin Lymphoma

Quantitative Assessment of Interim PET in Hodgkin Lymphoma: An Evaluation of the qPET Method in Adult Patients in the RAPID Trial